Bartlett & Co Wealth Management’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-36
Closed -$1.88K 1222
2025
Q2
$1.88K Buy
+36
New +$1.98K ﹤0.01% 1100
2021
Q4
Sell
-21
Closed -$2.75K 489
2021
Q3
$2.75K Buy
+21
New +$2.75K ﹤0.01% 836

Other funds holding CNMD

Bartlett & Co Wealth Management's CNMD Position: Q3 2025 in Review

Bartlett & Co Wealth Management sold out of CONMED (CNMD) in Q3 2025, closing a stake of 36 shares — an estimated $1.88K sold.

Bartlett & Co Wealth Management first reported a position in CNMD in Q3 2021 and held it in 2 quarters. The position peaked at $2.75K in Q3 2021. 273 funds tracked by Wall St. Rank hold CNMD as of Q3 2025.

  • Bartlett & Co Wealth Management reported no remaining CONMED position as of Q3 2025 after selling out during the quarter.
  • Bartlett & Co Wealth Management sold 36 CONMED shares in Q3 2025, an estimated $1.88K.
  • Bartlett & Co Wealth Management first reported a position in CONMED in Q3 2021 and held it in 2 quarters.
  • Bartlett & Co Wealth Management's CONMED position peaked at $2.75K in Q3 2021.
  • 273 funds tracked by Wall St. Rank held CONMED as of Q3 2025.

Based on Bartlett & Co Wealth Management's 13F filing for Q3 2025, filed 9 Oct 2025.